{"id":"W3172389519","doi":"10.1200/jco.2021.39.15_suppl.e18713","title":"Head-to-head comparison of first-line FOLFIRINOX versus gemcitabine plus nabpaclitaxel (GN) in advanced pancreatic cancer (APC): A target trial emulation using Canadian real-world data.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; FOLFIRINOX; Pancreatic cancer; Observational study; Hazard ratio; Randomized controlled trial; Gemcitabine; Internal medicine; Oncology; Clinical trial; Cancer; Irinotecan; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03856853,0.001524013,0.001874655,0.0007201497,0.0004987579,0.001039681,0.003075946,0.001481397,0.004412712],"category_scores_gemma":[0.0495022,0.0004952585,0.00528826,0.001063894,0.00115726,0.0008468198,0.001197884,0.0018281,0.0002532047],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01635436,"about_ca_system_score_gemma":0.01746793,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3340216,"about_ca_topic_score_gemma":0.3035319,"domain_scores_codex":[0.9834646,0.01331011,0.000477402,0.001002188,0.0009101246,0.0008355231],"domain_scores_gemma":[0.9762061,0.01566564,0.003635829,0.001627511,0.001787502,0.001077465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6120304,0.003878849,0.06005327,0.004948131,0.0350721,0.0003190115,0.0009129532,0.1740497,0.001229876,0.01348382,0.008886639,0.08513518],"study_design_scores_gemma":[0.2943052,0.1331778,0.1181284,0.001356628,0.05666956,0.0003526702,0.0006371834,0.3493714,0.003336139,0.01452882,0.02776274,0.0003734049],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9361925,0.006831869,0.01997427,0.001611672,0.0005385211,0.01700675,0.009046894,0.0002491542,0.008548311],"genre_scores_gemma":[0.9839475,0.0006655883,0.007707089,0.0004522874,0.00006064364,0.003019232,0.002524858,0.00001993889,0.001602828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6659784,"threshold_uncertainty_score":0.6641546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4738388426511597,"score_gpt":0.6103206065594997,"score_spread":0.13648176390834,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}